Garnet Anderson

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Biostatistics
MemberAppointed: 2002
University of Washington
School of Public Health and Community Medicine
Biostatistics
Affiliate Associate ProfessorAppointed: 1997

Mailing Address

Box 358080
MP-1002
Seattle, Washington 98195
United States

Contact Information

Phone: (206) 667-4699
Fax: (206) 667-4142
garnet@whi.org

Qualifications

Ph.D., University of Washington, Biostatistics, 1989.
M.S., State University of New York at Binghamton, Mathematics, 1983.

Expertise and Research Interests

My interests and areas of expertise are:
Design, analysis, and conduct of randomized trials
Biostatistics
Women's health
Chronic disease prevention research
Ovarian cancer, including biomarkers, screening, and risk

Keywords

COS Keywords:

Biomarkers, Biometry, Biostatistics, Cancer Or Carcinogenesis, Cancer Prevention, Clinical Trial, Disease Prevention, Ovarian Cancer, Public Health, Women's Health.

Additional Terms:

Biostatistics, Design and Analysis of Clinical Trials, Ovarian Cancer Screening, Prevention Trials, Trial Monitoring, Women's Health.

Memberships

American Statistical Association
International Biometric Society
Society for Controlled Clinical Trials

Previous Positions

1995-2002, Associate Member, Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Biostatistics
1989-1995, Assistant Member, Fred Hutchinson Cancer Research Center, Biostatistics, Public Health Sciences
1989-1997, Affiliate Assistant Professor, University of Washington, Public Health, Biostatistics

Funding Received

  • National Cancer Institute: Estimating Risk of Ovarian Cancer, , Oct 1, 2001 to Sep 30, 2004.

Publications

  • Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman J (2007) Long-term exposure to fine particulate matter air pollution and cardiovascular events in women, NEJM, 356 (5), 447-58
  • Anderson GL, Kooperverg C, Geller N, Rossouw JE, Pettinger M, Prentice RL (2007) Monitoring and reporting in the Women's Health Initiative hormone therapy trials, Clinical Trials, 4, 207-17
  • Chlebowski RT, Anderson GL, Geller M, Col N (2006) Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use, Clinical Breast Cancer, Suppl 2, S58-64
  • Prentice RL, Caan B, Chlebowski R, Patterson R, Kuller L, Ockene J, Margolis K, et al (including Anderson GL) (2006) Women's Health Initiative trial of a low-fat eating pattern and breast cancer, JAMA, 295, 629-42
  • Beresford SAA, Johnson KC, Ritenbaugh C, Lasser N, Snetselaar LG, Black HR, Anderson GL, et al (2006) Women's Health Initiative trial of a low-fat eating pattern and breast cancer, JAMA, 295, 643-54
  • Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al (including Anderson GL) (2006) Women's Health Initiative trial of a low-fat eating pattern and cardiovascular disease, JAMA, 295, 655-66
  • Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AA, Brunner RL, O'Sullivan MJ, et al (2006) Calcium and vitamin D supplementation and colorectal cancer in postmenopausal women: the Women's Health Initiative Randomized Trial, NEJM, 354, 684-96
  • Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins JR, Lewis CE, et al (including Anderson GL) (2006) The Women's Health Initiative Trial of calcium plus vitamin D supplementation on risk for fractures, NEJM, 354 (7), 669-83
  • Prentice RL, Langer RL, Stefanick M, Howard B, Pettinger M, Anderson GL, Barad D, Curb J, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J (2006) Combined analysis of Women's Health Initiative Observational and Clinical Trial data on postmenopausal hormone treatment and cardiovascular disease, American Journal of Epidemiology, 163, 589-99
  • Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett E, Lane DS, Hubbell FA, Assaf AR, Sarto G, Schenken R, Yasmeen S, Lessin L, Chlebowski RT (2006) Effects of conjugated equine estrogens on breast cancer and mommography in postmenopausal women with hysterectomy: the Women's Health Initiative randomized trial, JAMA, 295, 1647-57
  • Scholler N, Crawford M, Sato A, Drescher CW, O'Briant KC, Kivat N, Anderson GL, Urban ND (2006) Development of a CA-125 bead-based ELISA assay for use in small volume serum samples, Clinical Cancer Research, 12, 2117-24
  • Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, Curb JD, Hendrix SL, Hubbell FA, Khandekar J, Lane D, Lasser N, Lopez AM, Potter J, Ritenbaugh C (2006) Prior hormone therapy and breast cancer risk in the WHI Estrogen plus Progestin trial, Maturitas, 55 (2), 103-15
  • Sato AH, Anderson GL, Urban N, McIntosh, MW (2006) Comparing adaptive and non-adaptive algorithms for cancer early detection with novel biomarkers, Disease Biomarkers, 2, 151-62
  • Anderson GL, Leblanc M, Liu PY, Crowley J (2006) On use of covariates in randomization and analysis of clinical trials In Ankerst DP, Crowley J (eds), Handbook of Statistics in Clinical Oncology, 2 Edition, Boca Raton, Chapman and Hall/CRC Press (bookchapter)
  • Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators (Sep 2005) Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial., American Journal of Epidemiology, 162 (5), 404-14 Abstract
  • Stefanick ML, Prentice RL, Anderson G, Gass M, Manson JE, Hendrix SL, Vista-Deck D, McNeeley G, Women's Health Initiative Steering Committee (Apr 2005) Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit., Fertility and Sterility, 83 (4), 853-4 Abstract
  • Chlebowski RT, Anderson GL (Apr 2005) Progestins and recurrence in breast cancer survivors., Journal of the National Cancer Institute, 97 (7), 471-2 Abstract
  • Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (Mar 2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome., Journal of the National Cancer Institute, 97 (6), 439-48 Abstract
  • Prentice RL, Anderson GL, Armitage P, Colton T (2005) Women's Health Initiative: Statistical aspects and early results, Encyclopedia of Biostatistics, 2
  • Prentice RL, Pettinger M, Anderson GL (2005) Statistical issues arising in the Women's Health Initiative (with commentary and response), Biometrics, 61, 899-941
  • Prentice RL, Langer RL, Anderson GL, Barad D (2005) Response to commentary: "How Far Can Epidemiologists Get With Statistical Adjustment?", American Journal of Epidemiology, 162, 419-20
  • Gass M, Anderson GL, Barad D (Jan 2005) Concerns about published data from the estrogen-progestin (HT) arm of the, American Journal of Obstetrics and Gynecology, 192 (1), 333; author reply 33 Abstract
  • Anderson GL, Limacher M, Assaf AR, Bassf (April 2004) Effects of Conjugated Equine Estrogen in Postmenopausal Women With, Jama : the Journal of the American Medical Association, 291 (14), 1701-12 Abstract
  • Anderson GL, Judd HL, Kaunitz AM, Barad (October 2003) Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated, Jama : the Journal of the American Medical Association, 290 (13), 1739-48 Abstract
  • Anderson GL, Manson J, Wallace R, Lund B (October 2003) Implementation of the Women's Health Initiative Study Design, Annals of Epidemiology, 13 (9 Suppl), S5-17 Abstract
  • Hays J, Hunt JR, Hubbell FA, Anderson GL (October 2003) The Women's Health Initiative Recruitment Methods and Results, Annals of Epidemiology, 13 (9 Suppl), S18-77 Abstract
  • Harris RE, Chlebowski RT, Jackson RD, Fr (September 2003) Breast Cancer and Nonsteroidal Anti-inflammatory Drugs: Prospective, Cancer Research, 63 (18), 6096-101 Abstract
  • Etzioni R, Urban N, Ramsey S, McIntosh M (April 2003) The Case for Early Detection, Nature Reviews. Cancer, 3 (4), 243-52 Abstract
  • Pepe MS, Longton G, Anderson GL, Schumme (March 2003) Selecting Differentially Expressed Genes From Microarray Experiments, Biometrics, 59 (1), 133-42 Abstract
  • Shikany JM, Patterson RE, Agurs-Collins (March 2003) Antioxidant Supplement Use in Women's Health Initiative Participants, Preventive Medicine, 36 (3), 379-87 Abstract
  • Rossouw JE, Anderson GL, Prentice RL, La (July 2002) Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal, Jama : the Journal of the American Medical Association, 288 (3), 321-33 Abstract
  • Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, Francis J, Grimm R, Kotchen T, Langer R, Lasser N (Nov 2000) Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative., Hypertension, 36 (5), 780-9 Abstract
  • Crump C, McIntosh MW, Urban N, Anderson G, Karlan BY (Oct 2000) Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening., Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 9 (10), 1107-11 Abstract
  • Liu PY, Anderson G, Crowley JJ (Oct 2000) Observational studies and randomized trials., The New England Journal of Medicine, 343 (16), 1195; author reply 1 Abstract
  • Drescher C, Holt SK, Andersen MR, Anders (July 2000) Reported Ovarian Cancer Screening Among a Population-based Sample in Washington State, Obstetrics and Gynecology, 96 (1), 70-4 Abstract
  • Johnson SR, Anderson GL Barad DH, Stefan (2000) The Women's Health Initiative: Rationale, Design and Progress Report, Journal of the British Menopause Society, 5, 144-159
  • Anderson GL, Prentice RL (December 1999) Individually Randomized Intervention Trials for Disease Prevention and Control, Statistical Methods in Medical Research, 8 (4), 287-309 Abstract
  • Wang CY, Anderson GL, Prentice RL (Sep 1999) Estimation of the correlation between nutrient intake measures under restricted sampling., Biometrics, 55 (3), 711-7 Abstract
  • Women's Health Initiative Study Group (1998) Design of the Women's Health Initiative Clinical Trial and Observational Study, Controlled Clinical Trials, 19, 61-109
  • Freedman L, Anderson G, Kipnis V, Prenti (December 1996) Approached to Monitoring the Results of Long-term Disease Prevention Trials: Examples From the Women's Health Initiative, Controlled Clinical Trials, 17 (6), 509-25 Abstract
  • Goodman GE, Thornquist M, Kestin M, Metch B, Anderson G, Omenn GS (Oct 1996) The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 5 (10), 815-21 Abstract
  • Urban N, Taplin SH, Taylor VM, Peacock S, Anderson G, Conrad D, Etzioni R, White E, Montano DE, Mahloch J, Et Al. (Sep 1995) Community organization to promote breast cancer screening among women ages 50-75., Preventive Medicine, 24 (5), 477-84 Abstract
  • Kalhs P, Schwarzinger I, Anderson G, Mori M, Clift RA, Storb R, Buckner CD, Appelbaum FR, Hansen JA, Sullivan KM (Sep 1995) A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia., Blood, 86 (5), 2028-32 Abstract
  • Anderson GL and Fleming TR (1995) Model Misspecification in Proportional Hazards Regression, Biometrika, 82, 527-541
  • Busca A, Anasetti C, Anderson G, Appelbaum FR, Buckner CD, Doney K, Martin PJ, Petersdorf E, Sanders JE, Hansen JA (May 1994) Unrelated donor or autologous marrow transplantation for treatment of acute leukemia., Blood, 83 (10), 3077-84 Abstract
  • Pepe MS and Anderson GL (1994) A Cautionary Note on Inference for Marginal Regression Models With Longitudinal Data and General Correlated Response Data, Communications in Statistics, 23, 939-951
  • Urban N, Anderson GL, Peacock S (January 1994) Mammography Screening: How Important Is Cost As a Barrier to Use?, American Journal of Public Health, 84 (1), 50-5 Abstract
  • Bowen DJ, Henry H, Burrows E, Anderson G, Henderson MH (Nov 1993) Influences of eating patterns on change to a low-fat diet., Journal of the American Dietetic Association, 93 (11), 1309-11 Abstract
  • Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB (Sep 1993) Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 11 (9), 1729-36 Abstract
  • Thornquist MD, Omenn GS, Goodman GE, Gri (August 1993) Statistical Design and Monitoring of the Carotene and Retinol Efficacy Trial (CARET), Controlled Clinical Trials, 14 (4), 308-24 Abstract
  • Brodkin CA, Barnhart S, Anderson G, Checkoway H, Omenn GS, Rosenstock L (Jul 1993) Correlation between respiratory symptoms and pulmonary function in asbestos-exposed workers., The American Review of Respiratory Disease, 148 (1), 32-7 Abstract
  • Urban N, Anderson GL, Tseng A (May 1993) Effects on Response Rates and Costs of Stamps Vs Business Reply in a Mail Survey of Physicians, Journal of Clinical Epidemiology, 46 (5), 455-9 Abstract
  • Rowley SD, Anderson GL (May 1993) Effect of DMSO Exposure Without Cryopreservation on Hematopoietic Progenitor Cells, Bone Marrow Transplantation, 11 (5), 389-93 Abstract
  • Mickelson E, Smith A, McKinney S, Anderson G, Hansen JA (Feb 1993) A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucleotide probes to PCR-amplified DNA., Tissue Antigens, 41 (2), 86-93 Abstract
  • Omenn GS, and the CARET Co-Investigators (1993) Caret, the Beta-Carotene and Retinal Efficacy Trial to Prevent Lung Cancer in Asbestos-exposed Workers and in Smokers, Sourcebook on Asbestos Diseases, 219-241
  • Shy KK, Stergachis A, Grothaus LG, Wagner EH, Hecht J, Anderson G (Jun 1992) Tubal sterilization and risk of subsequent hospital admission for menstrual disorders., American Journal of Obstetrics and Gynecology, 166 (6 Pt 1), 1698-705; discussion Abstract
  • Urban N, White E, Anderson GL, Curry S, (May 1992) Correlates of Maintenance of a Low-fat Diet Among Women in the Women's Health Trial, Preventive Medicine, 21 (3), 279-91 Abstract
  • Kristal AR, White E, Shattuck AL, Curry (May 1992) Long-term Maintenance of a Low-fat Diet: Durability of Fat-related Dietary Habits in the Women's Health Trial, Journal of the American Dietetic Association, 92 (5), 553-9 Abstract
  • Omenn GS, Goodman G, Grizzle J, Thornquist M, Rosenstock L, Barnhart S, Anderson G, Balmes J, Cone J, Cherniack M, Et Al. (May 1992) Recruitment for the beta-carotene and retinol efficacy trial (CARET) to prevent lung cancer in smokers and asbestos-exposed workers., The Western Journal of Medicine, 156 (5), 540-4 Abstract
  • Pepe MS and Anderson GL (1992) Two Stage Experimental Designs: Early Stopping With a Negative Result, Applied Statistics, 41, 190-191
  • Omenn GS, Goodman G, Grizzle J, Thornqui (1992) Reccruitment for CARET, the Beta-Carotene and Retinal Efficacy Trial to Prevent Lung Cancer in Smokers and in Asbestos-exposed Workers, Western Journal of Medicine, 156, 540-544
  • Brawner DL, Anderson GL, Yuen KY (Jan 1992) Serotype prevalence of Candida albicans from blood culture isolates., Journal of Clinical Microbiology, 30 (1), 149-53 Abstract
  • Omenn GS, Goodman G, Grizzle J, Thornquist M, Rosenstock L, Barnhart S, Anderson G, Balmes J, Cherniack M, Cone J, Et Al. (Feb 1991) CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in asbestos-exposed workers and in smokers., Anti-cancer Drugs, 2 (1), 79-86 Abstract
  • Stergachis A, Shy KK, Grothaus LC, Wagner EH, Hecht JA, Anderson G, Normand EH, Raboud J (Dec 1990) Tubal sterilization and the long-term risk of hysterectomy., Jama : the Journal of the American Medical Association, 264 (22), 2893-8 Abstract
  • NCI Breast Cancer Screening Consortium (1990) Screening Mammography: a Missed Clinical Opportunity?, JAMA, 264, 54-58

Profile Details

Last Updated: 8/28/2007

COS Expertise ID #1192810
Reference this profile directly: http://myprofile.cos.com/anderson67